Skip to main content
. 2018 Jul 23;8:11088. doi: 10.1038/s41598-018-29445-z

Table 1.

Comparison table of the average composition ratio (%) of 15 biliary bile acids in CCA, BBD and PC patients.

CCA BBD (p-value) PC (p-value)
LCA 0.04 0.02 (NS) 0.02 (NS)
UDCA 0.15 1.32 (NS) 0.02 (NS)
CDCA 0.10 1.67 (NS) 1.00 (NS)
DCA 0.00 0.27 (NS) 0.31 (NS)
CA 0.27 2.37 (NS) 1.13 (NS)
GLCA 0.13 0.72 (NS) 0.32 (NS)
GUDCA 5.44 6.03 (NS) 2.66 (NS)
GCDCA 16.06 17.10 (NS) 14.22 (NS)
GDCA 1.37 4.97 (0.0009) 3.39 (0.2)
GCA 35.58 22.33 (<0.0001) 19.95 (<0.0001)
TLCA 0.01 0.10 (0.006) 0.06 (0.3)
TUDCA 1.48 2.75 (NS) 1.00 (NS)
TCDCA 7.31 12.45 (0.001) 13.82 (0.002)
TDCA 0.48 2.74 (0.004) 2.14 (0.1)
TCA 31.56 25.15 (0.04) 39.96 (0.04)

Datasets were analyzed using one-way analysis of variance (ANOVA) to determine if there is a significant difference in the average composition ratio (%) of biliary bile acids in CCA, BBD and PC patients. NS indicates that the ANOVA did not show a significant difference (p < 0.05) among the three patient groups. When ANOVA p < 0.05, p-values are indicated for pairwise comparisons between CCA and BBD patients and between CCA and PC patients (protected Fisher’s least significant difference (LSD) posthoc test).

HHS Vulnerability Disclosure